# Evonik to invest $220M in Lafayette lipid production expansion

Evonik announced plans to invest $220 million to expand operations in Lafayette, Indiana, adding a new factory to produce lipids for mRNA-based medicines. The project will create up to 80 jobs, with construction starting in 2023 and completion in 2025.

- Type: Expansion
- Announced: 2022-06-08
- Where: Lafayette, Indiana, United States
- Value: $220.0M
- Jobs: 80
- Starts operating: 2025
- Status: announced
- Products: lipids for mRNA-based medicines
- Sectors: [Specialty Chemicals](https://endata.com/sectors/specialty-chemicals.md)

## Companies

- [Evonik](https://endata.com/companies/15139.md)

## Sources

- [thecentersquare.com](https://www.thecentersquare.com/indiana/biomed-company-evonik-to-invest-220m-in-lafayette-expansion-receive-155m-in-incentives/article_b94499ae-e74d-11ec-bea6-b7327a1cd29c.html), 2022-06-08: "Evonik’s strategic expansion at Tippecanoe is fantastic news for the entire Greater Lafayette region."
- [buildingindiana.com](http://buildingindiana.com/stories/german-life-sciences-company-investing-220m,1968), 2022-06-27: "With this investment in lipid production, we are further expanding our leading position on the global market and specifically strengthening our Health Care business."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.